The technical genesis and practice of 8-aminoquinoline therapy of latent malaria offer
singular scientific, clinical, and public health insights. The 8-aminoquinolines brought …

Infections with Plasmodium falciparum and Plasmodium vivax cause over 600,000 deaths
each year, concentrated in Africa and in young children, but much of the world's population …

Background To achieve malaria elimination, Brazil must implement Plasmodium vivax
radical cure. We aimed to investigate the operational feasibility of point-of-care, quantitative …

Both safety and efficacy of medical treatment can vary depending on the ethnogeographic
background of the patient. One of the reasons underlying this variability is differences in …

Summary Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in erythrocytes causes
acute haemolytic anaemia upon exposure to fava beans, drugs, or infection; and it …

Background Endemic malaria occurring across much of the globe threatens millions of
exposed travelers. While unknown numbers of them suffer acute attacks while traveling …

Abstract Glucose-6-phosphate dehyrdgoenase (G6PD) deficiency is a common X-linked
genetic trait, with an associated enzyme phenotype, whereby males are either G6PD …

Background To reduce the risk of drug-induced haemolysis, all patients should be tested for
glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PDd) prior to prescribing …

Background Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is the most common
enzymopathy worldwide, no reliable bedside diagnostic tests to quantify G6PD activity exist …

Abstract Glucose-6-phosphate dehydrogenase (G6PD) deficiency caused by genetic
variants in the G6PD gene, constitutes the most common enzymopathy worldwide, affecting …